Researchers used Truveta Data from over 40,000 patients to assess whether newer GLP-1 RA medications semaglutide and tirzepatide, commonly known by brand names Ozempic, Wegovy, Mounjaro, and Zepbound are associated with lower risks of emergency department visits and hospitalizations related to alcohol use
8 This suggests that BRP not only reduces food intake but also enhances energy expenditure, making it a dual-action weight loss agent
doi: 10.1007/s11011-023-01271-x 191 LvHGuoMGuoCHeK
Medical Guidance That Feels Personal Youre paired with licensed clinicians who take time to understand your health, hormones, and goals
Symptoms such as fatigue or constipation may continue for longer, especially with dose escalation
The MHRA collects and monitors information on suspected safety concerns through its Yellow Card scheme